MAPK3 and nasopharyngeal carcinoma: In the present work, activation of the MAPK/ERK1/2 signaling pathway in nasopharyngeal carcinoma cells by a specific activator reduced the ability of isoimperatorin to downregulate the key proteins p-c-RAF, p-MEK, and p-ERK1/2.